CT引导精准微波消融术联合TACE术治疗原发性肝癌患者的临床效果

Clinical Effect of CT Guided Precise Microwave Ablation Combined with TACE in the Treatment of Patients with Primary Liver Cancer

目的:探究CT引导精准微波消融术联合肝动脉栓塞化疗术(TACE)治疗原发性肝癌患者的临床效果。方法:选择我院原发性肝癌患者82例,以随机抽签法分为对照组(n=41)和观察组(n=41)。对照组施行TACE术治疗,观察组采取CT引导精准微波消融术联合TACE术治疗,均治疗3个月。治疗3个月后统计两组临床效果及治疗后2年生存率、复发率。结果:治疗3个月后观察组总有效率70.73%较对照组48.78%高(P<0.05);观察组治疗后2年生存率73.17%高于对照组51.22%,复发率7.32%低于对照组26.83%(P<0.05)。结论:原发性肝癌患者予以CT引导精准微波消融术联合TACE术治疗能显著增强疗效,提升患者生存率,减少疾病复发。

Objective:To explore the clinical effect of CT guided precise microwave ablation combined with transcatheter arterial chemoembolization (TACE) in the treatment of patients with primary liver cancer.Methods:82 patients with primary liver cancer in our hospital were randomly divided into control group (n=41) and observation group (n=41).The control group was treated with TACE,while the observation group was treated with CT guided precise microwave ablation combined with TACE.All patients were treated for 3 months.After 3 months of treatment,the clinical efficacy and the 2 year survival rate and recurrence rate of the two groups were statistically analyzed.Results:After 3 months of treatment,the total effective rate of the observation group was 70.73%,which was higher than that of the control group 48.78%(P<0.05).The 2 year survival rate of the observation group was 73.17%,higher than that of the control group (51.22%),and the recurrence rate was 7.32%,lower than that of the control group (26.83%)(P<0.05).Conclusion:CT guided precise microwave ablation combined with TACE can significantly enhanee the curative effect,improve the survival rate and reduce the recurrence of the disease.